• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化血栓抽吸对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者心肌灌注及预后的影响

Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention.

作者信息

Xu Boning, Zhang Chunxin, Wei Wei, Zhan Yun, Yang Mingguo, Wang Yanjun, Zhao Jiajian, Lin Guiyang, Zhang Wen-Wen, Huo Xing, Shi Bin, Fan Ling

机构信息

Cardiovascular Department, The Fifth Clinical College of China Medical University-Bengang General Hospital of China Resources Medical Group, Benxi, China.

Cath Lab, The Fifth Clinical College of China Medical University-Bengang General Hospital of China Resources Medical Group, Benxi, China.

出版信息

Front Cardiovasc Med. 2023 Oct 4;10:1249924. doi: 10.3389/fcvm.2023.1249924. eCollection 2023.

DOI:10.3389/fcvm.2023.1249924
PMID:37859682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10584146/
Abstract

OBJECTIVE

To investigate the impact of optimized thrombus aspiration on myocardial perfusion, prognosis, and safety in patients with acute STsegment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention(primary PCI).

METHODS

A total of 129 patients with STEMI were randomly allocated into control group (Subgroup A and B) and experimental group(Subgroup C and D). Control group received percutaneous transluminal coronary angioplasty (PTCA),thrombus aspiration and primary PCI. Experimental group received optimized thrombus aspiration and primary PCI. The number of thrombus aspiration was less than 4 times in Subgroup A and C. The number of thrombus aspiration was performed more than 4 times in Subgroups B and D. The classification of thrombi extracted, the TIMI flow grade, the incidence of no-reflow and slow flow, cTFC, TPI and CK-MB at 12 h and 24 h after stenting, ST segment resolution of ECG after stenting, NT-proBNP, LVEFat 24 h, 30 days and 180 days after stenting were compared between groups. The incidence of intraoperative and postoperative bleeding complications, stroke events and major cardiovascular events (MACE) were recorded and compared between groups.

RESULTS

The classification of thrombi extracted in the experimental group was higher than that in the control group. The TIMI flow grade of the experimental group was better than the control group after thrombus aspiration. After stenting, the advantage still existed, but the difference was not statistically significant. On cTFC, the experimental group was lower than the control group, but the difference was not statistically significant; After stenting the experimental group was significantly lower than the control group. The CK-MB at 12 h and 24 h of the experimental group was lower than the control group. After thrombus aspiration the incidence of no-reflow in the experimental group was significantly lower than that in the control group; after stenting the incidence of no-reflow in the experimental group was still lower than the control group, but no statistically difference. After thrombus aspiration and stenting the incidence of slow flow in the experimental group were lower than that in the control group. After stenting, NT-proBNP at 24 h was lower in the experimental group than that in the control group, However, there was no statistical difference; after stenting, The NT-proBNP in the experimental group was lower than that in the control group at 30 days and 180 days. After stenting, LVEF of the experimental group was significantly higher than the control group at 24 h and 30 days; superiority remained after 180 days but no statistical difference. There was no statistical difference between two groups for intraoperative and postoperative bleeding complications, stroke events, and MACE events. In Subgroup analysis,there was no significant difference in the classification of thrombi extracted, TIMI flow grade, cTFC, CK-MB,NT-proBNP and LVEF between group C and D, but group A was better than group B. Analysis of variance showed that the optimal number of suction was 4-5 times.

CONCLUSIONS

Optimized thrombus aspiration can significantly improve myocardial perfusion and short-term and medium-term prognosis of STEMI patients after PCI, and reduce the incidence of slow flow and no-reflow. The optimal suction times were 4-5 times. Traditional aspiration method with more aspiration times is harmful to cardiac prognosis. Thrombus aspiration does not increase the incidence of stroke events and is safe.: identifier, ChiCTR2300073410.

摘要

目的

探讨优化血栓抽吸对接受直接经皮冠状动脉介入治疗(直接PCI)的急性ST段抬高型心肌梗死(STEMI)患者心肌灌注、预后及安全性的影响。

方法

将129例STEMI患者随机分为对照组(A、B亚组)和试验组(C、D亚组)。对照组接受经皮腔内冠状动脉成形术(PTCA)、血栓抽吸及直接PCI。试验组接受优化血栓抽吸及直接PCI。A、C亚组血栓抽吸次数少于4次。B、D亚组血栓抽吸次数超过4次。比较两组间抽出血栓的分类、TIMI血流分级、无复流和慢血流发生率、支架置入后12小时和24小时的校正TIMI帧数(cTFC)、心肌灌注指数(TPI)及肌酸激酶同工酶(CK-MB)、支架置入后心电图ST段回落情况、N末端B型利钠肽原(NT-proBNP)、支架置入后24小时、30天和180天的左室射血分数(LVEF)。记录并比较两组术中及术后出血并发症、卒中事件及主要心血管事件(MACE)的发生率。

结果

试验组抽出血栓的分类高于对照组。试验组血栓抽吸后TIMI血流分级优于对照组。支架置入后,优势依然存在,但差异无统计学意义。cTFC方面,试验组低于对照组,但差异无统计学意义;支架置入后试验组显著低于对照组。试验组12小时和24小时的CK-MB低于对照组。血栓抽吸后试验组无复流发生率显著低于对照组;支架置入后试验组无复流发生率仍低于对照组,但无统计学差异。血栓抽吸及支架置入后试验组慢血流发生率低于对照组。支架置入后,试验组24小时的NT-proBNP低于对照组,但无统计学差异;支架置入后30天和180天试验组的NT-proBNP低于对照组。支架置入后,试验组24小时和30天的LVEF显著高于对照组;180天后优势依然存在,但无统计学差异。两组术中及术后出血并发症、卒中事件及MACE事件无统计学差异。亚组分析显示,C组和D组在抽出血栓的分类、TIMI血流分级、cTFC、CK-MB、NT-proBNP及LVEF方面无显著差异,但A组优于B组。方差分析显示最佳抽吸次数为4 - 次。

结论

优化血栓抽吸可显著改善STEMI患者PCI术后的心肌灌注及短期和中期预后,并降低慢血流和无复流的发生率。最佳抽吸次数为4 - 5次。抽吸次数较多的传统抽吸方法对心脏预后有害。血栓抽吸不增加卒中事件的发生率且安全。试验注册号:ChiCTR2300073410 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/caf95828ff48/fcvm-10-1249924-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/385a69fb5eaa/fcvm-10-1249924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/12a093730c22/fcvm-10-1249924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/acf12770994f/fcvm-10-1249924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/a4cbac4b41a8/fcvm-10-1249924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/74c438cb5e54/fcvm-10-1249924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/a3819582c485/fcvm-10-1249924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/f960664d9212/fcvm-10-1249924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/875a733a5063/fcvm-10-1249924-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/caf95828ff48/fcvm-10-1249924-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/385a69fb5eaa/fcvm-10-1249924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/12a093730c22/fcvm-10-1249924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/acf12770994f/fcvm-10-1249924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/a4cbac4b41a8/fcvm-10-1249924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/74c438cb5e54/fcvm-10-1249924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/a3819582c485/fcvm-10-1249924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/f960664d9212/fcvm-10-1249924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/875a733a5063/fcvm-10-1249924-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a84/10584146/caf95828ff48/fcvm-10-1249924-g009.jpg

相似文献

1
Effect of optimized thrombus aspiration on myocardial perfusion and prognosis in acute ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention.优化血栓抽吸对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者心肌灌注及预后的影响
Front Cardiovasc Med. 2023 Oct 4;10:1249924. doi: 10.3389/fcvm.2023.1249924. eCollection 2023.
2
Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction.通过血栓抽吸导管冠状动脉内注射固定剂量硝普钠预防急性心肌梗死直接经皮冠状动脉介入治疗后的无复流现象
Exp Ther Med. 2013 Aug;6(2):479-484. doi: 10.3892/etm.2013.1139. Epub 2013 Jun 4.
3
Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.血栓抽吸联合梗死相关动脉内替罗非班给药改善急性心肌梗死患者直接经皮冠状动脉介入治疗中的心肌灌注。
Chin Med J (Engl). 2010 Apr 5;123(7):877-83.
4
Thrombus aspiration catheter improve the myocardial reperfusion of STEMI patients with high thrombus load during the emergency PCI operation.血栓抽吸导管可改善急诊经皮冠状动脉介入治疗(PCI)手术期间高血栓负荷的ST段抬高型心肌梗死(STEMI)患者的心肌再灌注。
J Cardiothorac Surg. 2019 Sep 23;14(1):172. doi: 10.1186/s13019-019-0974-z.
5
Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention: Influencing Factors and Intervention Strategies.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的心肌灌注:影响因素及干预策略
Cureus. 2023 Aug 2;15(8):e42841. doi: 10.7759/cureus.42841. eCollection 2023 Aug.
6
[Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction].急性心肌梗死患者直接经皮冠状动脉介入治疗期间冠状动脉内联合应用大剂量腺苷与替罗非班对比冠状动脉内应用替罗非班的疗效比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Oct;41(10):839-44.
7
IntraCoronary Artery Retrograde Thrombolysis vs. Thrombus Aspiration in ST-Segment Elevation Myocardial Infarction: Study Protocol for a Randomized Controlled Trial.ST段抬高型心肌梗死中冠状动脉内逆行溶栓与血栓抽吸的比较:一项随机对照试验的研究方案
Front Cardiovasc Med. 2022 Sep 15;9:928695. doi: 10.3389/fcvm.2022.928695. eCollection 2022.
8
Primary angioplasty and routine utilization of thrombus aspiration devices: feasibility and results in a consecutive series of 486 patients.原发性血管成形术及血栓抽吸装置的常规应用:486例连续病例的可行性及结果
J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):258-64. doi: 10.2459/01.JCM.0000263506.19415.23.
9
[Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty].[直接血管成形术中血栓抽吸联合梗死相关动脉内注射替罗非班的有效性及安全性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Oct;38(10):880-5.
10
Early Administration of Intracoronary Nitroprusside Compared with Thrombus Aspiration in Myocardial Perfusion for Acute Myocardial Infarction: A 3-Year Clinical Follow-Up Study.冠状动脉内硝普钠早期给药与血栓抽吸术对急性心肌梗死心肌灌注影响的比较:一项3年临床随访研究
Acta Cardiol Sin. 2015 Sep;31(5):373-80. doi: 10.6515/acs20150515a.

引用本文的文献

1
Identification and Management Strategies for Intracoronary High Thrombus Burden in Patients With STEMI: A Practical Experience and Literature Review.ST段抬高型心肌梗死患者冠状动脉内高血栓负荷的识别与管理策略:实践经验与文献综述
Rev Cardiovasc Med. 2025 Jul 30;26(7):37466. doi: 10.31083/RCM37466. eCollection 2025 Jul.
2
Impact of coronary flow restoration just before stent deployment in primary percutaneous coronary intervention.在直接经皮冠状动脉介入治疗中,支架置入前即刻恢复冠状动脉血流的影响。
Cardiovasc Interv Ther. 2025 Apr;40(2):306-315. doi: 10.1007/s12928-025-01088-8. Epub 2025 Jan 13.

本文引用的文献

1
Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.经皮冠状动脉介入治疗中冠状动脉内与静脉内推注替罗非班对 ST 段抬高型心肌梗死患者微血管阻塞的比较:一项心脏磁共振研究。
Int J Cardiovasc Imaging. 2020 Jun;36(6):1121-1132. doi: 10.1007/s10554-020-01800-0. Epub 2020 Feb 20.
2
Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.ST 段抬高型心肌梗死中冠状动脉微血管功能障碍的病理生理学和诊断。
Cardiovasc Res. 2020 Mar 1;116(4):787-805. doi: 10.1093/cvr/cvz301.
3
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon.
无复流现象的病理生理学、诊断和处理。
Cardiovasc Drugs Ther. 2019 Oct;33(5):589-597. doi: 10.1007/s10557-019-06901-0.
4
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南:欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
5
Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration.ST 段抬高型心肌梗死患者血栓抽吸:一项个体患者荟萃分析:血栓切除术试验者协作组。
Circulation. 2017 Jan 10;135(2):143-152. doi: 10.1161/CIRCULATIONAHA.116.025371. Epub 2016 Dec 9.
6
The no-reflow phenomenon in the young and in the elderly.年轻人和老年人中的无复流现象。
Int J Cardiol. 2016 Nov 1;222:1122-1128. doi: 10.1016/j.ijcard.2016.07.209. Epub 2016 Aug 2.
7
Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.ST段抬高型心肌梗死患者病变内注射与冠状动脉内注射阿昔单抗及血栓抽吸术的随机评估:COCTAIL II试验
Am Heart J. 2015 Dec;170(6):1116-23. doi: 10.1016/j.ahj.2015.08.020. Epub 2015 Sep 11.
8
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.ST段抬高型心肌梗死血栓抽吸术后的结局:前瞻性随机TOTAL试验的1年随访
Lancet. 2016 Jan 9;387(10014):127-35. doi: 10.1016/S0140-6736(15)00448-1. Epub 2015 Oct 22.
9
Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trial.ST段抬高型心肌梗死患者接受手动血栓切除术或单纯经皮冠状动脉介入治疗后罪犯病变的血栓负荷:TOTAL(血栓切除术与单纯PCI)试验的光学相干断层扫描亚研究
Eur Heart J. 2015 Aug 1;36(29):1892-900. doi: 10.1093/eurheartj/ehv176. Epub 2015 May 20.
10
Novel insights into an "old" phenomenon: the no reflow.对一种“古老”现象的新见解:无复流现象。
Int J Cardiol. 2015;187:273-80. doi: 10.1016/j.ijcard.2015.03.359. Epub 2015 Mar 26.